study of Nimbapatolpatra Kashaya â??Aaragwadhapatra lepa With Aaragwadhavrukshak Kashaya- Aaragwadhapatra lepa in Tinea.

A comparative clinical trial study to evaluate combined effect of Nimbapatolpatra Kashaya â??Aaragwadhapatra lepa With Aaragwadhavrukshak Kashaya- Aaragwadhapatra lepa in Dadru.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/038862

Enrollment

Registered

2021-12-23

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Nimbapatolpatra Kashaya â??Aaragwadhapatra lepa: Nimbapatolpatra Kashaya â?? 20 ml twice a day with anupan koshna jala Aaragwadhapatra lepa - pralep Control Intervention1: Aaragwadhavru

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical signs & symptoms of Dadru. The patients of both gender irrespective of caste,socio-economic status,religion, community, etc. Age group between 20-60 years. Washout period for previous medicine (Ex.Antifungal drugs,etc.) is of 15 days.

Exclusion criteria

Exclusion criteria: Patient on steroid treatment. Extensive Tinea. Tinea more than 2 years Tinea associated with other skin diseases. Tinea Unguium and Tinea Incognito. HIV infective patient.

Design outcomes

Primary

Measure	Time frame
To compare combined effect of â??Nimbapatolpatra kashya â??Aaragvadgapatralepaâ?? with â?? Aaragvadhavrukshak kashaya â?? Aaragvadhapatra lepaâ?? in Dadru.Timepoint: 5 days	—

Secondary

Measure	Time frame
to compare combined effect of Nimbapatolpatra kashay- aaragwadhpatra lepa with aaragwadhvrukshak kashay-aaragwadhpatra lepa in dadruTimepoint: 40 days	—

Countries

India

Contacts

Public ContactDr Abhinav Ravindra Sontakke

MAMs Sumatibhai Shah Ayurved College

jntayu@gmail.com9822829493

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026